Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by The300on Oct 17, 2011 7:57pm

232 Views

Post# 19157434

Depth and Thoughts

It looks like whoever had their foot on Halo's throat has decided to let it breathe a little.

Bids have been building and asks are being pulled.

Its either your classic case of manipulation (both up and down) or news is coming down the pipe and as always the inner circle is privy and accumulating. Either way, its nice to see some green instead of the perma-red we've been seeing these past few months.

I wouldn't be surprised to see news of Hudbay making an offer for either the entire company or parts of it at these bargin basement prices.

# Orders	Shares	Bid	Ask	Shares	# Orders
2	30000	0.130	0.145	23000	2
2	50500	0.125	0.180	34000	2
2	9000	0.120	0.195	3000	1
2	13000	0.115	0.210	1000	1
2	18000	0.110	0.250	5000	1